Serving Washington, DC • Maryland • Northern Virginia

Depression can persist even in highly capable, high‑functioning individuals.

For adults who have not responded adequately to traditional antidepressants, SPRAVATO® (esketamine) offers an FDA‑approved option for treatment‑resistant depression (TRD) and for depressive symptoms in major depressive disorder with suicidal thoughts or behaviors.

​

Our practice is a REMS‑certified SPRAVATO® treatment center, providing care in a private, medically supervised setting.

​

When to Consider SPRAVATO®

You may be a candidate if you:

​

• Have tried two or more antidepressants without sufficient improvement

• Continue to experience persistent depressive symptoms

• Are seeking an evidence‑based alternative to standard medication strategies

​

SPRAVATO® is used in combination with an oral antidepressant and integrated into a comprehensive treatment plan.

​

How It Works

Unlike conventional antidepressants that primarily affect serotonin pathways, SPRAVATO® works on the glutamate system (NMDA receptor modulation), targeting a different mechanism involved in depression.

Some patients experience improvement more rapidly than with traditional medication adjustments.

​

What to Expect

Treatment is provided in-office:

• Self-administered nasal spray under physician supervision

• Monitoring for at least two hours after each session

• Individualized dosing schedule following FDA protocol

​

Because temporary sedation or dissociation may occur, transportation home is required after each treatment.

​

Our Approach

 

We provide:

​

• Direct physician oversight

• Careful medical and psychiatric screening

• Ongoing medication management

• Coordination with psychotherapy when appropriate

​

As a private-pay practice, we maintain a low patient volume to ensure personalized, discreet care.

Documentation for out‑of‑network reimbursement is available upon request.

​

Schedule a Consultation

If you live in the DC metropolitan area and are exploring options for treatment‑resistant depression, contact our office to arrange a confidential consultation to determine whether SPRAVATO® therapy is appropriate for you.

​